By revolutionizing how we combat disease,warfare, and stimulate income growth, AI could fundamentally alter the terms of ...
Xtant Medical inks partnership with BioHorizons to expand access to Xtant's allogeneic growth factor into the dental market: Belgrade, Montana Friday, August 28, 2026, 16:00 Hrs [ ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 27, 2026 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical ...
Warmer, wetter conditions may spur an increase in hantavirus, West Nile virus and cyclospora infections across parts of the U ...
It has been said that the parts of a tree teach us lessons of spiritual significance,” writes columnist Joshua Siskin.
The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...
Eisai Limited ("Eisai") and Biogen Canada Inc. are pleased to receive Canada's Drug Agency (CDA-AMC)'s final positive ...
Experienced immunology R&D leader Dhavalkumar Patel, M.D., Ph.D., appointed Chair of the company’s Board of Directors - Steven Neier, ...
A recent report claimed wrongful diagnosis codes aided harmful transgender treatment, but proving fraud could be difficult ...
Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to release its preliminary results for financial year ending 30 June 2026.
We hear the bamboo rats before we see them. At the bottom of almost 200 concrete containers are hundreds of chunky rodents – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results